MDXG
MDXG where will price go from here? Looking at the long view.We've been on a downward channel since March 2018. Yesterday, we probed through the top into the previous gap and we also took out the monthly R3 price.
We have had higher lows (HL) and higher highs (HH) since beginning of 2019 on the Daily. Yesterday gave us another HH. THis important HH on May 30 also confirmed the trend change from the last low price in December 2018. We have an official trend change now with 2 HH's.
Risk reward is definitely in the Bullish favor with lots of upside and little downside potential.
From here:
1) we continue higher on news momentum
2) we consolidate for a while before pushing higher
3) we sell off after the pump
Possible future targets and places of interest:
Downside:
1) 2019 S1 price of $0.38- This would be a worse case scenario if the new board didn't happen and bad news comes out to tank it. Not likely.
Upside:
1) Continue filling in Gap to $6.12
2) $6.50 to $7 - this is the 2018 S2 and 2019 Pivot levels
3) $8.80 - this is the 2018 S1 level
4) $10.43 to $13.88 - This is a wide range that includes a large gap in price and also includes 2018 Pivot level at $12.50 and 2019 R1 level at $13.60
MiMedx (MDXG). End of correction. Targets 17.47MDXG
Correction could be over and we should wait the breakout of the structure to the upside.
Bullish divergence supports the idea.
Previous top could be the minimum target at 17.47.
MDXG buy in areaLooks like it's overbought and had a heavy push into a weekly upward TL.
Looking for cooling off and consolidation. Buy back in $15-16.
DSKX Begins To Rally After The Conference CallShares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products.
It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company, so if you haven't already, I highly encourage you to listen to today's conference call as soon as possible. Much larger company structure overall, significant increase in revenue, assets, cash flow and working capital with a very reputable management team to move the company forward. The fact that the current market cap is only 33M is what really gets me excited. Listen to the call to learn more:
The replay of the conference call can be heard by dialing 1-888-286-8010 in the United States and Canada or +1-617-801-6888 internationally, then referencing the Conference Passcode "56187013" A recording of the call can also be heard on the company website.
In the call, the DS Healthcare Group management team shared their motivations and answered questions relating to the business fundamentals on the Radiancy & Neova® deal, explaining how natural strategy alignment and synergies will lead to significant bottom line contribution.
The call was hosted by Mark Brockelman (CFO), Manny Gonzeles (CCO) and Renee Barch-Niles (CEO) and took place on Thursday, February 25th, 2016, at 8:30 a.m. EST.
-Renee Barch-Niles (CEO), an experienced CPG Executive who drove double-digit year-over-year growth in global food, drug, mass, club and specialty channels for Global companies such as Daymon Worldwide and Emilia Personal Care.
-Mark Brockelman (CFO) who has great experience in mergers and acquisitions, systems integration expertise and highly astute financial acumen. Mr. Brockelman Brockelman served as the Chief Financial Officer for National Dentex Corporation as well as the Senior Vice President/Chief Financial and Administrative Officer of the Miami Dolphins.
-Manny Gonzalez (CCO), a former top (NASDAQ: PG) Procter & Gamble executive managing a team of 7,000 sales representatives in the U.S., who has direct access to every major retailer in the country.
Acquisition Press Release Below:
finance.yahoo.com
For full disclose please visit: www.stockpicksnyc.com
